Medical management of endometriosis-associated pain

被引:60
作者
Mahutte, NG [1 ]
Arici, A [1 ]
机构
[1] Yale Univ, Sch Med, Dept Obstet & Gynecol, Div Reprod Endocrinol, New Haven, CT 06520 USA
关键词
D O I
10.1016/S0889-8545(02)00057-8
中图分类号
R71 [妇产科学];
学科分类号
100211 ;
摘要
Endometriosis-associated pain is among the most challenging conditions in gynecologic practice. It may be found in up to 60% of women with dysmenorrhea and 40% to 50% of women with pelvic pain or dyspareunia [1]. Despite this high prevalence, diagnosis is often delayed because of the need for surgical confirmation. When treatment is initiated it often achieves only partial success. Frequently, various treatments are attempted, tolerated to varying degrees, and rejected. This cycle may result in increasing frustration felt by the patient and the physician. It is not unusual for the resulting sense of despair to sever physician-patient relationships. This need not be the case. In recent years, various new insights into the medical treatment of endometriosis-associated pain have been gained. These developments should allow most women with endometriosis to find suitable relief. It is incumbent on physicians who provide gynecologic services to women of reproductive age to be intimately familiar with these treatments and the nuances of medication delivery and combination therapy.
引用
收藏
页码:133 / +
页数:19
相关论文
共 104 条
[51]   COMPARISON OF THE GONADOTROPIN-RELEASING-HORMONE AGONIST GOSERELIN ACETATE ALONE VERSUS GOSERELIN COMBINED WITH ESTROGEN-PROGESTOGEN ADD-BACK THERAPY IN THE TREATMENT OF ENDOMETRIOSIS [J].
KIILHOLMA, P ;
KORHONEN, M ;
TUIMALA, R ;
HAGMAN, E ;
KIVINEN, S .
FERTILITY AND STERILITY, 1995, 64 (05) :903-908
[52]   Immunobiology of endometriosis [J].
Lebovic, DI ;
Mueller, MD ;
Taylor, RN .
FERTILITY AND STERILITY, 2001, 75 (01) :1-10
[53]  
LUCIANO AA, 1988, OBSTET GYNECOL, V72, P323
[54]   DANAZOL - ENDOCRINE CONSEQUENCES IN HEALTHY WOMEN [J].
LUCIANO, AA ;
HAUSER, KS ;
CHAPLER, FK ;
SHERMAN, BM .
AMERICAN JOURNAL OF OBSTETRICS AND GYNECOLOGY, 1981, 141 (06) :723-727
[55]   ENDOMETRIAL PATTERNS DURING THERAPY WITH DANAZOL OR GESTRINONE FOR ENDOMETRIOSIS - STRUCTURAL AND ULTRASTRUCTURAL-STUDY [J].
MARCHINI, M ;
FEDELE, L ;
BIANCHI, S ;
DINOLA, G ;
NAVA, S ;
VERCELLINI, P .
HUMAN PATHOLOGY, 1992, 23 (01) :51-56
[56]   THE MOS 36-ITEM SHORT-FORM HEALTH SURVEY (SF-36) .2. PSYCHOMETRIC AND CLINICAL-TESTS OF VALIDITY IN MEASURING PHYSICAL AND MENTAL-HEALTH CONSTRUCTS [J].
MCHORNEY, CA ;
WARE, JE ;
RACZEK, AE .
MEDICAL CARE, 1993, 31 (03) :247-263
[57]   THE MOS 36-ITEM SHORT-FORM HEALTH SURVEY (SF-36) .3. TESTS OF DATA QUALITY, SCALING ASSUMPTIONS, AND RELIABILITY ACROSS DIVERSE PATIENT GROUPS [J].
MCHORNEY, CA ;
WARE, JE ;
LU, JFR ;
SHERBOURNE, CD .
MEDICAL CARE, 1994, 32 (01) :40-66
[58]  
MELDRUM DR, 1988, FERTIL STERIL, V50, P400
[59]   Historical prospective cohort study of the recurrence of pain after discontinuation of treatment with danazol or a gonadotropin-releasing hormone agonist [J].
Miller, JD ;
Shaw, RW ;
Casper, RFJ ;
Rock, JA ;
Thomas, EJ ;
Dmowski, WP ;
Surrey, E ;
Malinak, LR ;
Moghissi, K .
FERTILITY AND STERILITY, 1998, 70 (02) :293-296
[60]   Quantification of endometriosis-associated pain and quality of life during the stimulatory phase of gonadotropin-releasing hormone agonist therapy: A double-blind, randomized, placebo-controlled trial [J].
Miller, JD .
AMERICAN JOURNAL OF OBSTETRICS AND GYNECOLOGY, 2000, 182 (06) :1483-1487